בחינת תאי הריאה במעבדה באוניברסיטה העברית
Hebrew University researchers looking at lung cells
Photo: Daniel Hanoch
Hebrew University researchers looking at lung cells

Israeli researchers find existing drug eradicates coronavirus from lungs

Scientists from Hebrew University and Mount Sinai Medical Center say they worked out what makes the virus so dangerous to human lungs and how to diminish the virus' severity using widely-used anti-cholesterol medicine

i24NEWS, Ynet |
Published: 07.14.20 , 22:38
Israeli researchers from the Hebrew University in Jerusalem said they found how and existing drug, used for treating excessive fat in blood cells, could be effective in significantly reducing the severity of coronavirus.
  • Follow Ynetnews on Facebook and Twitter

  • Prof. Ya’acov Nahmias and Mount Sinai Medical Center’s Dr. Benjamin tenOever claimed in a new research that the FDA-approved drug called "Fenofibrate" (Tricor), normally used to treat high cholesterol, could make the effects of COVID-19 feel like a common cold or eradicate it from the lungs altogether.
    בחינת תאי הריאה במעבדה באוניברסיטה העבריתבחינת תאי הריאה במעבדה באוניברסיטה העברית
    Hebrew University researchers looking at lung cells
    (Photo: Daniel Hanoch)
    The research, done over the past three months by Prof. Nahmias' team and scientists at Mount Sinai, postulates the novel coronavirus needs an accumulation of fat inside lung cells in order to reproduce itself.
    “By understanding how the SARS-CoV-2 (scientific name for coronavirus) controls our metabolism, we can wrestle back control from the virus and deprive it of the very resources it needs to survive,” Nahmias told the Jerusalem Post.
    פרופ' קובי נחמיאס פרופ' קובי נחמיאס
    Prof. Ya’acov Nahmias
    (Photo: Daniel Hanoch)
    The findings of the study explain why high blood sugar and cholesterol levels, are highly dangerous factors for COVID-19 carriers, even without having diabetes.
    Using different lung samples, the drug was able to eradicate the virus almost completely within five days of treatment, according to the research.
    “Our findings may indeed significantly reduce the global burden of COVID-19,” Dr. tenOever said as quoted by outlet Globes.

    Talkbacks for this article 0